SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001104659-11-026190
Filing Date
2011-05-05
Accepted
2011-05-05 12:45:14
Documents
4
Period of Report
2011-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q a11-9427_110q.htm 10-Q 774273
2 EX-31.1 a11-9427_1ex31d1.htm EX-31.1 13178
3 EX-31.2 a11-9427_1ex31d2.htm EX-31.2 13913
4 EX-32.1 a11-9427_1ex32d1.htm EX-32.1 10160
  Complete submission text file 0001104659-11-026190.txt   812704
Mailing Address 119 FOURTH AVE NEEDHAM MA 02494-2725
Business Address 119 FOURTH AVE NEEDHAM MA 02494 7814330771
Celldex Therapeutics, Inc. (Filer) CIK: 0000744218 (see all company filings)

IRS No.: 133191702 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-15006 | Film No.: 11813559
SIC: 2835 In Vitro & In Vivo Diagnostic Substances